1 대한골대사학회 지침 위원회, "골다공증 진단 및 치료 지침 2007" 대한내분비학회 23 (23): 76-108, 2008
2 Moschen AR, "The RANKL/OPG system and bone mineral density in patients with chronic liver disease" 43 : 973-983, 2005
3 Janes CH, "Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice" 95 : 2581-2586, 1995
4 Rezaieyazdi Z, "Reduced bone density in patients on long-term warfarin" 12 : 130-135, 2009
5 Valla DC, "Primary Budd-Chiari syndrome" 50 : 195-203, 2009
6 Arteh J, "Prevalence of vitamin D deficiency in chronic liver disease" 55 : 2624-2628, 2010
7 Hamada T, "Metalloproteinase-9 deficiency protects against hepatic ischemia/reperfusion injury" 47 : 186-198, 2008
8 Wang C, "Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations" 159 : 507-514, 2008
9 Szalay F, "High serum osteoprotegerin and low RANKL in primary biliary cirrhosis" 38 : 395-400, 2003
10 López-Larramona G, "Hepatic osteodystrophy: an important matter for consideration in chronic liver disease" 3 : 300-307, 2011
1 대한골대사학회 지침 위원회, "골다공증 진단 및 치료 지침 2007" 대한내분비학회 23 (23): 76-108, 2008
2 Moschen AR, "The RANKL/OPG system and bone mineral density in patients with chronic liver disease" 43 : 973-983, 2005
3 Janes CH, "Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice" 95 : 2581-2586, 1995
4 Rezaieyazdi Z, "Reduced bone density in patients on long-term warfarin" 12 : 130-135, 2009
5 Valla DC, "Primary Budd-Chiari syndrome" 50 : 195-203, 2009
6 Arteh J, "Prevalence of vitamin D deficiency in chronic liver disease" 55 : 2624-2628, 2010
7 Hamada T, "Metalloproteinase-9 deficiency protects against hepatic ischemia/reperfusion injury" 47 : 186-198, 2008
8 Wang C, "Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations" 159 : 507-514, 2008
9 Szalay F, "High serum osteoprotegerin and low RANKL in primary biliary cirrhosis" 38 : 395-400, 2003
10 López-Larramona G, "Hepatic osteodystrophy: an important matter for consideration in chronic liver disease" 3 : 300-307, 2011
11 Goral V, "Hepatic osteodystrophy and liver cirrhosis" 16 : 1639-1643, 2010
12 Collier JD, "Guidelines on the management of osteoporosis associated with chronic liver disease" 50 (50): i1-i9, 2002
13 Ferrari S, "For the IOF Committee of Scientific Advisors Working Group on Osteoporosis Pathophysiology: Osteoporosis in young adults: pathophysiology, diagnosis, and management" 23 : 2735-2748, 2012
14 Pereira FA, "Etiopathogenesis of hepatic osteodystrophy in Wistar rats with cholestatic liver disease" 85 : 75-83, 2009
15 Khosla S, "Epidemiology and clinical features of osteoporosis in young individuals" 15 : 551-555, 1994
16 Watts NB, "Endocrine Society: Osteoporosis in men: an Endocrine Society clinical practice guideline" 97 : 1802-1822, 2012
17 Holick MF, "Endocrine Society: Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline" 96 : 1911-1930, 2011
18 Ebeling PR, "Clinical practice. Osteoporosis in men" 358 : 1474-1482, 2008
19 Collier J, "Bone disorders in chronic liver disease" 46 : 1271-1278, 2007
20 Hofbauer LC, "Approach to the patient with secondary osteoporosis" 162 : 1009-1020, 2010